TRADITIONAL POSTER - ismrm
TRADITIONAL POSTER - ismrm
TRADITIONAL POSTER - ismrm
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Poster Sessions<br />
2478. Preliminary Results Using a Split Dynamic Time Series for DCE MR-Mammography<br />
Kjell-Inge Gjesdal 1 , Endre Grøvik 2 , Atle Bjørnerud 3 , Kathinka Kurz Dæhli 4<br />
1 Sunnmøre MR-klinikk, Aalesund, Norway; 2 University of Oslo, Oslo, Norway; 3 Rikshospitalet University Hospital, Oslo, Norway;<br />
4 Stavanger University Hospital, Stavanger, Norway<br />
This work presents the preliminary results of an ongoing MR-mammography study. In this study two dynamic sequences are run in an interleaved fashion<br />
during contrast enhancement. By using this approach both high temporal and high spatial resolution images can be produced and analyzed for the evaluation<br />
of breast cancer using one single dose of a Gd-based contrast agent. A comprehensive list of biomarkers is presented along with their statistical values.<br />
2479. Can Diffusion Weighted Imaging/Apparent Diffusion Coefficient Mapping and Dynamic Contrast<br />
Magnetic Resonance Imaging Provide Histological Phenotyping of Breast Cancer in Basal and Luminal<br />
Subtypes?<br />
Michael A. Jacobs 1 , Riham H. El Khouli 2 , Katarzyna J. Macura 1 , Sarah Mezban 1 , Ihab Kamel 1 , David A.<br />
Bluemke 2<br />
1 The Russell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins University School of Medicine,<br />
Baltimore, MD, United States; 2 Department of Radiology and Imaging Sciences, National Institutes of Health, Bethesda, MD, United<br />
States<br />
By using a combined DWI/ADC and DCE approach to investigate histological characteristics of breast cancer a better understanding of breast cancer<br />
aggressiveness can be realized. Functional imaging such as DWI and DCE-MR is feasible and thus, combined DWI/ADC mapping, and DCE-MR provides<br />
radiological biomarkers of molecular environment and could provide targets for image-guided biopsy of highly aggressive tumor regions.<br />
2480. Principal Component Analysis of Breast DCE-MRI: Evaluation of Clinical Protocols at Two<br />
Temporal Resolutions<br />
Daria Badikhi 1 , Myra Shapiro-Feinberg 2 , Erez Eyal 3 , Edna Furman-Haran 4 , Dov Grobgeld 1 , Hadassa<br />
Degani 1<br />
1 Biological Regulation, Weizmann Institute of Science, Rehovot, Israel; 2 Radiology, Meir Medical Center, Kfar Sabah, Israel;<br />
3 Biological Regulation, Weizmann Institute of Science, Israel; 4 Biological Services, Weizmann Institute of Science, Rehovot<br />
Principal component analysis (PCA) of clinical breast DCE MRI datasets, recorded at two different temporal resolutions (80 s and 120 s), was tested and<br />
evaluated for its diagnostic ability. We found that PCA can differentiate with high accuracy between benign and malignant lesions at both temporal<br />
resolutions, however, discriminative ability between invasive ductal and lobular carcinoma can be reached only at the higher temporal resolution. Overall,<br />
PCA was found to be a useful, standardized, fast, and objective tool for computer aided diagnosis of breast lesions<br />
2481. Diffusion Weighted and Dynamic Contrast Enhanced MRI in Evaluation of Treatment Effects During<br />
Neoadjuvant Chemotherapy in Breast Cancer Patients<br />
Line R. Jensen 1 , Benjamin Garzon 1 , Mariann G. Heldahl 1 , Tone F. Bathen 1 , Pål E. Goa 1 , Steinar<br />
Lundgren 1,2 , Ingrid S. Gribbestad 1<br />
1 Department of Circulation and Medical Imaging, Norwegian University of Science and Technology, Trondheim, Norway;<br />
2 Department of Oncology, St. Olavs University Hospital, Trondheim, Norway<br />
The purpose of this study was to use MRI for early evaluation of treatment effects in breast cancer patients undergoing neoadjuvant chemotherapy, and to<br />
identify MRI parameters at 3T that correlate to treatment response. In addition, the reproducibility of diffusion weighted MRI was assessed. The ADC values<br />
from two baseline examinations showed good reproducibility, with ICC of 0.84. The best predictors of pathologic treatment response were the change in the<br />
longest diameter measured on MRI, followed by mean and skewness of ADC, and Ktrans entropy.<br />
2482. Assessing 3D Resolution of DCE-MRI for Optimization and Standardization of Breast Screening<br />
Protocols<br />
Marco Borri 1 , Maria Schmidt 1 , Erica Scurr 1 , Toni Wallace 1 , Steven Allen 1 , Nandita deSouza 1 , Martin O.<br />
Leach 1<br />
1 CR-UK and EPSRC Cancer Imaging Centre, Institute of Cancer Research and Royal Marsden Hospital, Sutton, Surrey, United<br />
Kingdom<br />
Spatial resolution of 3D fat-suppressed DCE pulse sequences depends on many parameters, and parity of protocols across breast screening centres is highly<br />
desirable. The objective of this work was to propose methods for quality assurance in breast screening programmes. We compared the image quality<br />
achieved with two different k-space sampling patterns, Radial and Linear, on a breast screening sequence. Resolution was evaluated with Test Objects and<br />
on Clinical Data, and, considering all three directions, was superior for Linear. The Image Analysis methodologies used were found to be robust and<br />
reproducible, and are therefore candidates to become quality assurance tools.<br />
2483. Influence of Spatial Heterogeneity on the Diagnostic Accuracy of DCE-MRI in Breast Tumor<br />
Characterization<br />
Endre Grøvik 1 , Kjell-Inge Gjesdal 2 , Kathinka Kurz Dæhli 3 , Atle Bjørnerud 4<br />
1 University of Oslo, Oslo, Norway; 2 Sunnmøre MR-klinikk, Aalesund, Norway; 3 Stavanger University Hospital, Stavanger, Norway;<br />
4 Rikshospitalet University Hospital, Oslo, Norway<br />
This study investigates the influence of spatial heterogeneity on the diagnostic accuracy of DCE-MRI in breast tumor characterization. This is done by<br />
comparing the lesions VOI 50th-percentile versus VOI 95th-percentile values for a defined set of pharmacokinetic parameters, based on their ability for<br />
differentiating between malignant and benign lesions. Our results suggest that a significant improvement in diagnostic accuracy can be obtained by<br />
identifying the 5% region indicating the highest malignancy in the defined tumor VOI.